Results of the comprehensive care program for patients with diabetic foot

Authors

  • Perla María Trujillo Pedroza Policlínico Docente "Manuel Piti Fajardo"
  • Maite George Arce Policlínico Docente "Manuel Piti Fajardo"
  • Yanet Valdés Morales Hospital Clínico Quirúrgico Universitario "Arnaldo Milián Castro"
  • Justo Ricardo Ortega Sánchez Policlínico Docente "Manuel Piti Fajardo"
  • Asiris Mendoza Molina Policlínico Docente "Manuel Piti Fajardo"

Keywords:

diabetes mellitus, diabetic foot, risk foot, Heberprot-p

Abstract

Introduction: diabetes mellitus is acknowledged as a worldwide threat. The early identification of the risk factors associated with the appearance of ulcers in people with diabetes mellitus is crucial to avoid future amputations. Objective: to describe the results of the Comprehensive Diabetic Foot Care Program. Method: a descriptive, retrospective, cross-sectional study of 567 diabetic patients who attended consultation was conducted at the Manuel Piti Fajardo Polyclinic in Santo Domingo from January 2010 to December 2017. The sample consisted of two groups: 225 patients who were treated with heberprot-p and 342 who presented a risk foot. Results: from 2010 to 2017, the proposal of the program was increased by 69.3%. Of the 225 patients who were treated with heberprot-p, 87.1% had a satisfactory evolution. The proportion of amputation in the period was 19.15% (from 2016 to 2017 it was 0%). Patients with relapses share modifiable risk factors. Diabetic foot ulcers are detected in early stages, which reduces the number of applications of heberprot-p by patients (between six and seven vials); the average cost also decreased. The patients with a risk foot were 342: 16.2% with low risk, 26.4% with moderate risk, 20.6% with high risk and 36.8% with no risk. Conclusions: the heberprot-p therapy was effective, as well as the timely treatment of diabetic patients with a risk foot in order to reduce the incidence of injuries.

Downloads

Download data is not yet available.

Author Biographies

Perla María Trujillo Pedroza, Policlínico Docente "Manuel Piti Fajardo"

Especialista de I y II Grado Medicina General Integral. Profesora Auxiliar. Diplomada en Atención Integral al Paciente Diabético. Diplomada en Gestión de la Información y el Conocimiento.

Maite George Arce, Policlínico Docente "Manuel Piti Fajardo"

Licenciada en Enfermería. Diplomada en atención integral al pie diabético.

Yanet Valdés Morales, Hospital Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista de I Grado en Medicina General Integral y en Imagenología. Máster en Atención Integral a la Mujer. Profesora Asistente de la Universidad de Cencias Médicas de Villa Clara.

Justo Ricardo Ortega Sánchez, Policlínico Docente "Manuel Piti Fajardo"

Especialista de I Grado en Medicina Interna. Diplomado en Cardiología Hospitalaria. Profesor Asistente.

References

1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017. Disponible en: http://www.diabetesatlas.org

2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care [Internet]. 2010 Jan [citado 2 Sept 2017];35(Suppl 1):S64-S71. Disponible en: http://care.diabetesjournals.org/content/35/Supplement_1/S64

3. Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2016 [Internet]. La Habana: Minsap; 2017 [citado 2 Sept 2017]. Disponible en: http://files.sld.cu/dne/files/2017/05/Anuario_Estad%C3%ADstico_de_Salud_e_2016_edici%C3%B3n_2017.pdf

4. Barshes NR, Saedi S, Wrobel J, Kougias P, Kundakcioglu OE, Armstrong DG. Journal of Diabetes and Its Complications [Internet]. 2017 Apr [citado 12 Abr 2018];31(4): 700–707. Disponible en: https://wwww.unboundmedicine.com/medline/citation/28153676/A_model_to_estimate_cost_savings_in_diabetic_foot_ulcer_prevention_efforts_

5. Fernández-Montequín JI, Betancourt BY, Leyva-Gonzalez G, Mola EL, Galán-Naranjo K, Ramírez-Navas M, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete woundclosure. Int Wound J [Internet]. 2009 Feb [citado 12 Abr 2018];6(1):67-72. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19291119

6. Trujillo Pedrosa PM, George Arse M, Ortega Sánchez JR. Complicación que se presenta en los pacientes al tratamiento con heberprot-p en un área de salud. Acta Méd Centro [Internet]. 2017 [citado 10 Nov 2017];11(2):[aprox. 8 p.]. Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/827

7. Rodríguez Gurrí D, González Expósito A. Necesidad de un programa integral de prevención del pie diabético para la formación de Especialista de Medicina General Integral. Correo Cient Méd Holguín [Internet]. 2011 [citado 10 Nov 2017];15(3):[aprox. 4 p.]. Disponible en: http://www.cocmed.sld.cu/no153/pdf/vista02.pdf

8. Álvarez Crespo AR, Alonso Carbonell L, Yera Alós I, García Milián AJ. Evolución clínica de pacientes con úlcera del pie diabético tratados con Heberprot-P. AMC [Internet]. 2013 Sep-Oct [citado 10 Nov 2017];17(5):544-57. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102502552013000500004

9. Silva Pupo M, González Moya IA, Valenciano García Y, González Cedeño M. Evolución de lesiones complejas en el pie diabético con uso de Heberprot-P®. AMC [Internet]. 2015 Jul-Ago [citado 10 Nov 2017];19(4):357-65. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552015000400007

10. Martínez Garrido R, Montano Iglesias E, Hernández Vázquez C, Tejera Díaz JF, González González L, Méndez Romero M. Tratamiento eficaz con Heberprot-P en la evolución de las úlceras del pie diabético. Portales Méd [Internet]. 2014 Abr [citado 10 Nov 2017]:1-5. Disponible: http://www.revista-portalesmedicos.com/revista-medica/tratamiento-heberprot-p-ulceras-pie-diabetico/

11. González Benavides C, Pérez Mederos LM, Peraltas Pérez G. Resultados de la utilización del heberprot-P®. Acta Méd Centro [Internet]. 2014 [citado 7 Feb 2018];8(4):16-23. Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/192/280

12. Hernández Cañete CM, González Pacheco HH, Sánchez Montiel ME, Vega García R. Tratamiento con Heberprot-P en la provincia Ciego de Ávila. Rev Cubana Angiol Cir Vasc [Internet]. 2009 [citado 7 Feb 2018];10(1):12-21. Disponible en: http://bvs.sld.cu/revistas/ang/vol10_1_09/ang03109.htm

13. Turns M. Prevention and management of diabetic foot ulcers. Br J Community Nurs [Internet]. 2015 Mar [citado 10 Nov 2017]; Suppl Wound Care: S30, S32, S34-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25757381

14. Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE [Internet]. 2015 May [citado 8 Jun 2018];10(5):e0124446. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0124446

15. Estévez Perera A, García García Y, Licea Puig ME, Alfonso Fundora A, Álvarez Delgado H. Identificación de las deformidades podálicas en personas con diabetes mellitus, una estrategia para prevenir amputaciones. Rev Cubana Endocrinol [Internet]. 2013 Dic [citado 8 Jun 2018];24(3):297-313. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532013000300006&lng=es

16. Frómeta Ríos V, Neyra Barrios RM. Efectividad de un programa educativo en pacientes con pie diabético de riesgo. MEDISAN [Internet]. 2015 Ene [citado 22 Ene 2018];19(1):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000100011

17. Rodríguez Gurri D. Caracterización de los pacientes con pie diabético tratados con Heberprot-P en el Hospital Militar de Holguín. Rev Cubana Angiol Cir Vasc [Internet]. 2014 [citado 8 Jun 2018];15(1):39-46. Disponible en: http://scielo.sld.cu/pdf/ang/v15n1/ang06114.pdf

18. Casanova Moreno Md, Bayarre Vea HD, Navarro Despaigne DA, Sanabria Ramos G, Trasancos Delgado M. Estrategia educativa dirigida a adultos mayores diabéticos tipo 2 y proveedores de salud. Rev Cubana Med Gen Integr [Internet]. 2018 [citado 1 Dic 2018];34(1):[aprox. 12 p.]. Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/222

19. Mora Marcial GR, Verdecia Tamallo K, Rodríguez Vergara TM, del Pino BN, Guerra Cabrera C. Adherencia terapéutica en pacientes con algunas enfermedades crónicas no transmisibles. Rev Cubana Med Gen Integr [Internet]. 2017 [citado 22 Ene 2018];33(3):[aprox. 12 p.]. Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/309/146

20. Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ, International Working Group on the Diabetic Foot. The IWGDF guidance on the management and prevention of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev [Internet]. 2016 Jan [citado 21 Jun 2018];32(supl 1):2-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26409930

21. Kiani J, Goharifar H, Moghimbeigi A, Azizkhani H. Prevalence and risk factors of five most common upper extremity disorders in diabetics. J Res Health Sci [Internet]. 2014 [citado 22 Ene 2018];14(1):92-5. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24402858

Downloads

Published

2019-01-01

How to Cite

1.
Trujillo Pedroza PM, George Arce M, Valdés Morales Y, Ortega Sánchez JR, Mendoza Molina A. Results of the comprehensive care program for patients with diabetic foot. Acta Méd Centro [Internet]. 2019 Jan. 1 [cited 2025 Jul. 1];13(1):63-71. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/982

Issue

Vol. 13 No. 1 (2019): January-March

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).